But here's why you likely won't be seeing it in your doctor's office anytime soon.

Add Yahoo as a preferred source to see more of our stories on Google. Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. ...

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

Blood tests that detect a protein involved in Alzheimer’s disease could help predict the age at which the disease may strike people long before they develop symptoms, according to a new study. But ...

The simple blood test that can predict dementia risk in women years before symptoms appear - British researchers welcomed the study and said blood tests to pick up Alzheimer’s disease early were devel ...

When it comes to cancer, waiting for symptoms may soon be old news. Telehealth company Hims & Hers began offering a blood test this week that screens for a wide range of cancers before warning signs ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

What Is an MCV Blood Test? MCV stands for mean corpuscular volume. An MCV blood test measures the average size of red blood cells, which have the critical job of carrying oxygen to your organs. If ...

Justin Stebbing does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...